FRANZ HEFTI

Profile

First Name

: FRANZ

Middle Name

:

Last Name

: HEFTI

Related Companies
Titles
Company Name
Related People
DIRECTOR
EMBERA NEUROTHERAPEUTICS INC
ROSS BARRETT, ROSS P. BARRETT, JOHN BEAIRD, NICHOLAS GOEDERS, NICHOLAS E. GOEDERS, ROBERT LINKE, ROBERT B. LINKE, JOSEPH LOVETT, JOSEPH P. LOVETT
DIRECTOR
QR PHARMA, INC.
PAUL BLAKE, HAL BRODERSON, HAL S. BRODERSON, CLAUDINE BRUCK, DHESH GOVENDER, HENRY HAGOPIAN, GREGORY S. HARRIMAN, FRANZ F. HEFTI, MICHAEL HOFFMAN, MARIA MACCECCHINI, MARIA L. MACCECCHINI, REID MCCARTHY, BARBARA S. SCHILBERG, ROBERT WHELAN, MARK WHITE
DIRECTOR
EMBERA NEUROTHERAPEUTICS, INC.
ROSS BARRETT, ROSS P. BARRETT, JOHN BEAIRD, NICHOLAS GOEDERS, NICHOLAS E. GOEDERS, ROBERT LINKE, ROBERT B. LINKE, JOSEPH LOVETT, JOSEPH P. LOVETT
DIRECTOR
COGNITION THERAPEUTICS INC
MARK BREEDLOVE, SUSAN CATALANO, AARON FLETCHER, ROBERT GAILUS, FRANZ F. HEFTI, NADA JAIN, KENNETH MOCH, KENNETH I. MOCH, HAROLD SAFFERSTEIN, HAROLD T. SAFFERSTEIN, STEPHEN SANDS, IRWIN SCHER, PEGGY WALLACE
DIRECTOR, PROMOTER
ACUMEN PHARMACEUTICALS, INC.
WILLIAM F. GOURE, GRANT KRAFFT, MARK LAMPERT, DANIEL J. O-CONNELL, DAVID W. SUMMA, JURGEN WEBER
DIRECTOR
ALZHEON, INC.
SUSAN ABUSHAKRA, M.D., MICHAEL ACETI, ADEM ALBAYRAK, MENGHIS BAIRU, FRANKLIN BERGER, ADAM HALE BROCKMAN, CHRISTOPHER NOEL DUNN, NOEL DUNN, NEIL W. FLANZRAICH, JEAN-PIERRE GARNIER, JORDAN HELLER, JOHN HEY, JOHN ANTHONY HEY, JOHN HEY, PH.D., DIANE K. JORKASKY, M.D., DENNIS LANGER, KEN MACE, KENNETH A. MACE, GREGORY LEON MILLER, SCOTT MINICK, DAVID NIKODEM, DAVID NIKODEM, PH.D., GLENN E. PAULY, AIDAN POWER, MRCPSYCH, GINO SANTINI, MUNEER SATEER, MUNEER SATTER, ROBERT SILVERMAN, JEAN-PIERRE SOMMADOSSI, MARTIN TOLAR, MARTIN TOLAR, M.D., PH.D., MARK VERSAVEL, JEREMY YONGXIN YU
DIRECTOR
SPINOGENIX, INC.
DAN ALBOSTA, STELLA SARRAF, STELLA SARRAF, PH.D., VINCENT SIMMON, JERRE STEAD, JERRE L. STEAD, JOSH SWARTZ, MERVYN TURNER, MERVYN TURNER, PH.D., PETER VANDERKLISH, PETER WHITNEY VANDERKLISH, STEVE YOUNG
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-02-24
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-19 
2020-09-17
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Debt 
2019-08-29 
2018-09-05
D/A
Link
BIOTECHNOLOGY 
PHARMACEUTICAL PREPARATIONS [2834] 
DECLINE TO DISCLOSE 
Equity 
2017-05-25 
2018-05-07
D/A
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-20 
2017-10-04
D
Link
OTHER HEALTH CARE 
 
DECLINE TO DISCLOSE 
Equity 
2017-09-20 
2017-06-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2017-05-25 
2016-11-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2016-11-18 
2016-03-31
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-03-21 
2016-02-26
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2016-02-04 
2015-09-29
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2015-07-27
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2015-07-13 
2015-07-22
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-20 
2015-04-10
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-20 
2015-02-25
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-30 
2015-01-23
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-19 
2015-01-09
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-12-30 
2014-04-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2014-03-20 
2013-09-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-20 
2013-05-15
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2013-04-18 
2013-01-03
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2012-12-20 
2011-12-06
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2011-12-05 
2011-08-16
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2011-08-02 
2010-04-26
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2010-04-14 
2010-03-10
D/A
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-10-22 
2010-01-15
D
Link
PHARMACEUTICALS 
 
NO REVENUES 
Debt 
2010-01-04 
2009-11-05
D
Link
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
 
2009-10-22